Altimmune, Inc. (ALT) Tops Q3 EPS by 4c

Altimmune, Inc. (NASDAQ: ALT) reported Q3 EPS of ($0.32), $0.04 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Iran weighs letting Europe clear mines in the Strait of Hormuz - Bloomberg
• Joseph Massela Launches AurumX Consulting to Expand Trusted Access to Global Precious Metals Markets
• Shopify (SHOP) call put ratio 2.6 calls to 1 put into quarter results